Sotalol Hydrochloride Tablet
Product Images NDC 69584-844

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 69584-844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oxford Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

69584-841-10 (69584 841 10)

Label for Sotalol Hydrochloride Tablets USP, 80 mg strength, oral dosage form. The label indicates a quantity of 100 tablets, labeled by Oxford Pharmaceuticals, LLC. Includes the NDC number 69584-841-10 and storage instructions. The label also features a barcode and a designated serialization area.*

FDA Label Image

69584-842-10 (69584 842 10)

Label for Sotalol Hydrochloride Tablets USP 120 mg oral tablets, containing 100 tablets per bottle. The label displays the National Drug Code (NDC) 69584-842-10, and states the product is manufactured by Oxford Pharmaceuticals, LLC in Birmingham, Alabama. The label includes storage instructions and dosage information reference.*

FDA Label Image

69584-843-10 (69584 843 10)

Label for Sotalol Hydrochloride Tablets USP 160 mg oral tablets, supplied in a 100-tablet count. The label includes the NDC 69584-843-10, manufacturer Oxford Pharmaceuticals, LLC, Birmingham, Alabama, and storage instructions for 20° to 25°C. Serialization area and barcode are also visible.*

FDA Label Image

69584-844-10 (69584 844 10)

Label for Sotalol Hydrochloride Tablets USP, 240 mg oral tablets, 100 count. Manufactured by Oxford Pharmaceuticals, LLC in Birmingham, Alabama. The label includes storage instructions, a serialization area, and the NDC number 69584-844-10. The label is predominantly beige with blue and red text and features the Oxford Pharmaceuticals logo at the bottom.*

FDA Label Image

Age About 2 Years Or Younger (Age Factor)

A pharmacokinetic chart depicting the relationship between Age Factor and Age in months. The graph shows an increasing curve where Age Factor approaches 1.0 as age rises, with the x-axis labeled from 0.1 to over 50 months and y-axis displaying Age Factor from 0.0 to 1.0, noting that Age Factor equals 1 for ages over 24 months.*

FDA Label Image

Figure 2 (Figure2)

This is a Kaplan-Meier survival curve chart depicting recurrence-free survival over time (days) for oral Sotalol Hydrochloride at doses of 80 mg, 120 mg, and 160 mg compared with placebo. The chart includes log-rank P-values for each dose versus placebo to indicate statistical significance.*

FDA Label Image

Figure 3 (Figure3)

A survival curve chart comparing recurrence-free survival over time (in days) between oral Sotalol Hydrochloride and placebo groups. The graph shows higher recurrence-free survival for the Sotalol Hydrochloride group across the study period up to 180 days, with a log-rank p-value of 0.002 indicating statistical significance.*

FDA Label Image

Molecular Structure (Molecularstructure)

Chemical structure diagram of sotalol hydrochloride, showing its molecular components and arrangement, as commonly depicted in pharmaceutical labeling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.